Does higher erythropoietic activity divert iron into red blood cell production and lower storage iron while hemoglobin and hematocrit stay high-normal?

Under certain physiological conditions, the body prioritizes oxygen-carrying capacity over systemic iron storage, establishing a trade-off between active red blood cell production and tissue iron reserves.

Clinical and physiological evidence

• Prioritized erythropoiesis: Elevated erythropoietic activity—driven by stimuli such as altitude exposure, hypoxia, or testosterone administration—preferentially shunts systemic iron directly toward the erythron to support heme and hemoglobin synthesis.
• Storage depletion with preserved indices: As iron is actively pulled out of hepatic and macrophage stores to meet high marrow demands, storage iron (measured via serum ferritin) is depleted. Because red blood cell production is prioritized, hemoglobin and hematocrit levels remain within high-normal or elevated ranges. This physiological state represents absolute iron deficiency without anemia (IDWA).

Mechanistic pathways

• Erythroferrone secretion: Increased erythropoietic drive stimulates erythroblasts to produce and secrete the hormone erythroferrone (ERFE) in response to erythropoietin (EPO) stimulation.
• Hepcidin suppression: ERFE acts directly on the liver to inhibit BMP-SMAD signaling, which in turn suppresses the transcription of hepcidin, the master iron regulator.
• Ferroportin mobilization: Lower circulating hepcidin levels prevent the degradation of the iron exporter ferroportin. This enhances iron release from macrophages and duodenal enterocytes into the bloodstream, maximizing the mobilization and utilization of iron for active erythropoiesis.

Bottom line

• Higher erythropoietic activity successfully prioritizes and shunts iron into active red blood cell production, maintaining high-normal hemoglobin and hematocrit levels at the direct expense of depleting systemic storage iron (ferritin).